Shepherd Center: The Andrew C. Carlos Multiple Sclerosis Institute at Shepherd

Print This Page

Email This Page

About MS

Multiple sclerosis (MS) affects more than 400,000 Americans and 7,000 Georgians. Although there is no cure for MS, it is treatable. Treatments can slow the progression of the disease and make a difference in people's lives. Read more about Multiple Sclerosis.

The Andrew C. Carlos Multiple Sclerosis Institute at Shepherd

The Andrew C. Carlos MS Institute at Shepherd has extensive experience treating people with multiple sclerosis (MS), suspected MS or related disorders. The MS Institute at Shepherd has treated thousands of people with MS using a wide range of neurological and rehabilitative services.

We believe that early and appropriate treatment results in better quality of life for people with MS and may protect against future illness. Our staff of medical professionals work aggressively to slow the progression of the disease.

Treatment options focus on medications, physical rehabilitation (including strength and energy conservation) and experimental therapies. The MS Institute at Shepherd offers comprehensive evaluations, diagnostics, rehabilitation services and treatment options through FDA-approved drugs and new clinical trials.

Appointments and General Information

Call the MS Institute at Shepherd if you would like to inquire about our program or schedule an appointment or follow-up visit.

Phone: 404-352-2020
Hours: 8:30 a.m. – 4 p.m. Monday – Friday

Treatment Options

Review our list of services available at the MS Institute at Shepherd.
Read More

Meet our Treatment Team
Read about the medical team at the MS Institute at Shepherd.
Read More

Frequently Asked Questions
Many questions you may have are answered in our Frequently Asked Questions.
Read More

MS Research
The MS Institute at Shepherd participates in a number of MS research studies and clinical trials. We believe that an emphasis on clinical trials and new clinical treatment investigations means the latest treatments are often available to our clients before they are available elsewhere. In addition, the MS Institute at Shepherd is a leader in the management of the most current medications, multi-drug regimes and MS clinical drug trials.
Read More

Affilitations
The MS Institute at Shepherd is a member of the Consortium of MS Institutes and the North American Research Committee on Multiple Sclerosis. It is an officially designated treatment facility of the National MS Society, Georgia Chapter and is a partner with Harvard Medical School and other leading academic institutions.

Subscribe to our Newsletter
The MS Institute publishes The Synapse newsletter twice each year. The newsletter contains news about new medications, tips for managing MS, research on the horizon and other information pertaining to MS.

Click here to view our latest edition. To subscribe, send an email to Emily Cade.